Status:

RECRUITING

Study of BDNF Pathway Biomarkers in the Cerebrospinal Fluid in Patients With Huntington's Disease

Lead Sponsor:

University Hospital, Montpellier

Conditions:

Huntington Disease

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

Huntington disease (HD, 1.3/10 000) is an autosomal dominant disease due to an abnormal expansion of CAG triplets in HTT gene. Several pathophysiological mechanisms have been evoked, including an alt...

Detailed Description

* Design: Multicentre prospective case-control study. Centres: University Hospital of Montpellier, France; University Hospital of Bordeaux, France; University Hospital of Nimes, France; University Hos...

Eligibility Criteria

Inclusion

  • General inclusion criteria:
  • age ≥ 18 years-old
  • national health insurance cover
  • Patients inclusion criteria:
  • genetically confirmed Huntington's disease diagnosis (≥ 35 CAG repeat in HTT gene exon 1)
  • written informed consent
  • only for patients "with lumbar puncture (LP)": patient agreement for LP
  • Control inclusion criteria:
  • anterior LP for medical reason with consent for biobank "Neuro" with following samples present in this biobank : 2 mL blood + 0.5 mL plasma + 0.5 mL cerebrospinal fluid
  • information and non-opposition for the finality of this biobank
  • paired by age with a patient (+/- 5 years difference)

Exclusion

  • General exclusion criteria:
  • protected by law
  • Patients exclusion criteria:
  • Huntington's disease stage too Evolved that may interfere with cognitive evaluations or MRI
  • contraindications to brain MRI
  • only for patients "with LP": contraindications to LP
  • incapacity to give informed consent
  • Control exclusion criteria:
  • neurodegenerative of inflammatory central nervous system pathology

Key Trial Info

Start Date :

March 3 2020

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

February 1 2026

Estimated Enrollment :

135 Patients enrolled

Trial Details

Trial ID

NCT04012411

Start Date

March 3 2020

End Date

February 1 2026

Last Update

September 30 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University Hospital of Montpellier

Montpellier, France